Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL28595629 | 0.99 | POLB (0.34) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL3141829 | 0.95 | THRB (0.36) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL28333248 | 0.91 | THRB (0.41) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL29353135 | 0.91 | THRB (0.34) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL11210985 | 0.91 | ALDH1A1 (0.36) | THRBPOLBAPEX1HTTTDP1 | |
| SCHEMBL14973716 | 0.90 | THRB (0.34) | THRBTSHR | |
| Acrylamide SCHEMBL28703253 | 0.89 | THRB (0.32) | THRBPOLBAPEX1HTTTDP1 | |
| Methacrylic Acid SCHEMBL5992325 | 0.86 | THRB (0.35) | THRBTSHRCA1CA2 | |
| Methacrylic Acid SCHEMBL10598884 | 0.86 | TSHR (0.51) | THRBPOLBAPEX1HTTTDP1 | |
| Methacrylic Acid SCHEMBL17823491 | 0.85 | TSHR (0.53) | THRBPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230384482-A1 | SANDWICH COLORED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-30 | — | — | US | claimed |
| US-11278503-B2 | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions | NOVALIQ GMBH (DE) | 2022-03-22 | — | — | US | claimed |
| US-20260137558-A1 | OPHTHALMIC DEVICE | Able Tx Ltd. (IL) | 2026-05-21 | — | — | US | disclosed |
| US-12629057-B2 | System for collecting and utilizing health data | MENICON CO., LTD. (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12629906-B2 | System and method to manufacture a contact lens with an embedded element | ALCON INC. (CH) | 2026-05-19 | — | — | US | disclosed |
| WO-2026099827-A1 | LIGHT ABSORBERS FOR OPHTHALMC LENS MATERALS AND DEVICES | ALCON INC. (CH) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132236-A1 | LIGHT ABSORBERS FOR OPHTHALMC LENS MATERALS AND DEVICES | ALCON INC (CH) | 2026-05-14 | — | — | US | disclosed |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-05-14 | — | — | US | disclosed |
| EP-4304842-B1 | METHOD FOR MAKING PHOTOFUNCTIONAL CONTACT LENSES | ALCON INC (CH) | 2026-05-06 | — | — | EP | disclosed |
| US-20260118700-A1 | DIFFRACTIVE MULTIFOCAL CONTACT LENS | ALCON INC (CH) | 2026-04-30 | — | — | US | disclosed |
| EP-3976381-B1 | PAD TRANSFER PRINTING INSTRUMENT AND METHOD FOR MAKING COLORED CONTACT LENSES | ALCON INC (CH) | 2026-04-29 | — | — | EP | disclosed |
| EP-3976381-A1 | PAD TRANSFER PRINTING INSTRUMENT AND METHOD FOR MAKING COLORED CONTACT LENSES | Alcon Inc. (CH) | 2022-04-06 | — | — | EP | disclosed |
| WO-2022061132-A1 | OPHTHALMIC DEVICES FOR THE TREATMENT OR AMELIORATION OF DRY EYE DISEASE, AND RELATED METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-03-24 | — | — | WO | disclosed |
| US-11278503-B2 | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions | NOVALIQ GMBH (DE) | 2022-03-22 | — | — | US | disclosed |
| CN-114206849-A | Therapeutic methods for treating non-infectious ocular immunoinflammatory disorders | 斯格本斯眼科研究所有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20220079877-A1 | DEVICES AND METHODS FOR REDUCING CYSTINE CRYSTALS IN VIVO | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2022-03-17 | — | — | US | disclosed |
| WO-2022053791-A1 | COLOURED CONTACT LENS | COOPERVISION INTERNATIONAL LIMITED (GB) | 2022-03-17 | — | — | WO | disclosed |
| US-20220075210-A1 | CONTACT LENS | COOPERVISION INTERNATIONAL LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |
| US-11256003-B2 | Weekly and monthly disposable water gradient contact lenses | ALCON INC. (CH) | 2022-02-22 | — | — | US | disclosed |
| CN-109718376-B | Ophthalmic product with anti-allergy and relieving effects | 晶硕光学股份有限公司 | 2022-01-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629906-B2 | System and method to manufacture a contact lens with an embedded element | GCN1, RPL7, DSTN | THRB 2824/4885POLB 2899/4885APEX1 3938/4885 |
| US-20260132236-A1 | LIGHT ABSORBERS FOR OPHTHALMC LENS MATERALS AND DEVICES | RAD51, ERCC1, LANCL2 | THRB 824/4885POLB 4060/4885APEX1 2711/4885 |
| US-12629057-B2 | System for collecting and utilizing health data | LAGE3, SUMO1, USP36 | THRB 2401/4885POLB 3964/4885APEX1 4436/4885 |
| US-20260137558-A1 | OPHTHALMIC DEVICE | IL2, ICOS, TRHDE | THRB 246/4885POLB 4595/4885APEX1 4529/4885 |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | CRYZ, CRYAB, CRYAA | THRB 945/4885POLB 4215/4885APEX1 1760/4885 |
| US-20260118700-A1 | DIFFRACTIVE MULTIFOCAL CONTACT LENS | DSG1, SDC1, DSP | THRB 2841/4885POLB 3507/4885APEX1 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.